Cargando…

The Extended Surgical Concepts for Hepatocellular Carcinoma in the Era of Immune Checkpoint Inhibitors

Surgical resection remains one of the most effective curative therapies for HCC. However, the majority of patients have advanced unresectable diseases upon presentation. It is of paramount importance to raise the resectability of patients with HCC. The remarkable objective response rate reported by...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hsu, Hsiao-Mei, Tsai, Hsin-I, Lee, Wei-Chen, Wang, Chih-Chi, Yu, Ming-Chin, Lin, Shi-Ming, Lin, Chun-Yen, Wu, Chi-Huan, Lee, Chao-Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Case Series
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612521/ https://www.ncbi.nlm.nih.gov/pubmed/37901716 http://dx.doi.org/10.2147/JHC.S433598

Ejemplares similares

Variations in the AURKA Gene: Biomarkers for the Development and Progression of Hepatocellular Carcinoma
por: Wang, Bin, et al.
Publicado: (2018)

Delayed Hepatocellular Carcinoma Recurrence After Liver Transplantation: Comprehensive Clinical Characterization of Case Series
por: Wong, Ta-Hsiang, et al.
Publicado: (2022)

Predictors of Response and Survival in Immune Checkpoint Inhibitor-Treated Unresectable Hepatocellular Carcinoma
por: Lee, Pei-Chang, et al.
Publicado: (2020)

Potential Role and Significance of Ocular Demodicosis in Patients with Concomitant Refractory Herpetic Keratitis
por: Hung, Kuo-Hsuan, et al.
Publicado: (2020)

The efficacy of immune checkpoint inhibitors in thoracic malignancies
por: Remon, Jordi, et al.
Publicado: (2021)

A proposal for T1 subclassification in hepatocellular carcinoma: reappraisal of the AJCC 8th edition
por: Lee, Chao-Wei, et al.
Publicado: (2022)

Stationary Trend in Elevated Serum Alpha-Fetoprotein Level in Hepatocellular Carcinoma Patients
por: Yen, Yi-Hao, et al.
Publicado: (2023)

Hepatic resection for hepatocellular carcinoma in the octogenarian: is it justified?
por: Lee, Chao-Wei, et al.
Publicado: (2019)

Risk of HBV reactivation in patients with immune checkpoint inhibitor-treated unresectable hepatocellular carcinoma
por: Lee, Pei-Chang, et al.
Publicado: (2020)

The clinical value of cardiopulmonary exercise testing in the modern era
por: Laveneziana, Pierantonio, et al.
Publicado: (2021)

Liver resection for hepatocellular carcinoma larger than 10 cm: A multi-institution long-term observational study
por: Lee, Chao-Wei, et al.
Publicado: (2021)

Utilizing Experimental Mouse Model to Identify Effectors of Hepatocellular Carcinoma Induced by HBx Antigen
por: Yang, Ming-Hui, et al.
Publicado: (2020)

CCL4 Stimulates Cell Migration in Human Osteosarcoma via the mir-3927-3p/Integrin αvβ3 Axis
por: Tsai, Hsiao-Chi, et al.
Publicado: (2021)

Real-world outcome of immune checkpoint inhibitors for advanced hepatocellular carcinoma with macrovascular tumor thrombosis
por: Tsai, Hong-Ming, et al.
Publicado: (2021)

Low-dose methotrexate-induced ulcerated psoriatic plaques: A rare case
por: Hsu, Ming-Chun, et al.
Publicado: (2015)

Causes of Death among Patients with Hepatocellular Carcinoma According to Chronic Liver Disease Etiology
por: Yen, Yi-Hao, et al.
Publicado: (2023)

The Dynamic Change of Immune Checkpoints and CD14+ Monocytes in Latent Tuberculosis Infection
por: Wang, Ping-Huai, et al.
Publicado: (2021)

Post genomics era for orchid research
por: Tsai, Wen-Chieh, et al.
Publicado: (2017)

Gut microbiota and metabolites associate with outcomes of immune checkpoint inhibitor–treated unresectable hepatocellular carcinoma
por: Lee, Pei-Chang, et al.
Publicado: (2022)

Peroxisome Proliferator-Activated Receptor γ Expression Is Inversely Associated with Macroscopic Vascular Invasion in Human Hepatocellular Carcinoma
por: Hsu, Hui-Tzu, et al.
Publicado: (2016)

CTGF increases matrix metalloproteinases expression and subsequently promotes tumor metastasis in human osteosarcoma through down-regulating miR-519d
por: Tsai, Hsiao-Chi, et al.
Publicado: (2014)

Correction: CTGF increases matrix metalloproteinases expression and subsequently promotes tumor metastasis in human osteosarcoma through down-regulating miR-519d
por: Tsai, Hsiao-Chi, et al.
Publicado: (2020)

Clinical outcomes for patients with thymoma and thymic carcinoma after undergoing different front‐line chemotherapy regimens
por: Ma, Wei‐Li, et al.
Publicado: (2022)

Precision medicine and personalising therapy in pulmonary hypertension: seeing the light from the dawn of a new era
por: Savale, Laurent, et al.
Publicado: (2018)

Severe Inflammatory Colitis Related to Encorafenib and Binimetinib following Immune Checkpoint Inhibitor Therapy
por: Issac, Aaron G., et al.
Publicado: (2022)

Immune checkpoint blockade in glioblastoma: from tumor heterogeneity to personalized treatment
por: Arrieta, Víctor A., et al.
Publicado: (2023)

Normal Alpha-Fetoprotein Hepatocellular Carcinoma: Are They Really Normal?
por: Lee, Chao-Wei, et al.
Publicado: (2019)

Irinotecan dose reduction in metastatic colorectal cancer patients with homozygous UGT1A1*28 polymorphism: a single-center case series
por: Tsai, Hsiang-Lin, et al.
Publicado: (2022)

Using the Chinese herb Scutellaria barbata against extensively drug-resistant Acinetobacter baumannii infections: in vitro and in vivo studies
por: Tsai, Chin-Chuan, et al.
Publicado: (2018)

Developing trustworthy recommendations as part of an urgent response (1–2 weeks): a GRADE concept paper
por: Akl, Elie A., et al.
Publicado: (2021)

Statin use is associated with a lower risk of recurrence after curative resection in BCLC stage 0-A hepatocellular carcinoma
por: Yang, Shih-Yu, et al.
Publicado: (2021)

NPRL2 down‐regulation facilitates the growth of hepatocellular carcinoma via the mTOR pathway and autophagy suppression
por: Wang, Ya‐Chin, et al.
Publicado: (2022)

Response Prediction in Immune Checkpoint Inhibitor Immunotherapy for Advanced Hepatocellular Carcinoma
por: Hung, Hao-Chien, et al.
Publicado: (2021)

Significance of Aurora B overexpression in hepatocellular carcinoma. Aurora B Overexpression in HCC
por: Lin, Zhong-Zhe, et al.
Publicado: (2010)

Preclinical verification of the efficacy by targeting peptide-linked liposomal nanoparticles for hepatocellular carcinoma therapy
por: Wu, Cheng-Der, et al.
Publicado: (2019)

Severe Diarrhea in the Setting of Immune Checkpoint Inhibitors
por: Kuo, Jean R., et al.
Publicado: (2018)

Stapleless laparoscopic left lateral sectionectomy for hepatocellular carcinoma: reappraisal of the Louisville statement by a young liver surgeon
por: Lee, Chao-Wei, et al.
Publicado: (2018)

Laparoscopic Liver Resection Should Be a Standard Procedure for Hepatocellular Carcinoma with Low or Intermediate Difficulty
por: Gau, Ruoh-Yun, et al.
Publicado: (2021)

Prenatal Exposure to Air Pollution and Immune Thrombocytopenia: A Nationwide Population-Based Cohort Study
por: Yen, Hsin-Chien, et al.
Publicado: (2022)

Role of autophagy-related protein in the prognosis of combined hepatocellular carcinoma and cholangiocarcinoma after surgical resection
por: Perng, Daw-Shyong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s9h22t5f6ap868lfa6suafhfar